Cas no 89561-01-3 (3,8-Dihydroxy-4(15),10(14),11(13)-guaiatrien-12,6-olide; (1α,3β,5α,6α,8α)-form, 8-O-(2,3-Dihydroxy-2-methylpropanoyl))

3,8-Dihydroxy-4(15),10(14),11(13)-guaiatrien-12,6-olide; (1α,3β,5α,6α,8α)-form, 8-O-(2,3-Dihydroxy-2-methylpropanoyl) structure
89561-01-3 structure
Product Name:3,8-Dihydroxy-4(15),10(14),11(13)-guaiatrien-12,6-olide; (1α,3β,5α,6α,8α)-form, 8-O-(2,3-Dihydroxy-2-methylpropanoyl)
CAS No:89561-01-3
MF:C19H24O7
MW:364.389666557312
CID:596613
Update Time:2024-03-01

3,8-Dihydroxy-4(15),10(14),11(13)-guaiatrien-12,6-olide; (1α,3β,5α,6α,8α)-form, 8-O-(2,3-Dihydroxy-2-methylpropanoyl) Chemical and Physical Properties

Names and Identifiers

    • Propanoic acid, 2,3-dihydroxy-2-methyl-,dodecahydro-8-hydroxy-3,6,9-tris(methylene)-2-oxoazuleno[4,5-b]furan-4-yl ester
    • Propanoic acid, 2,3-dihydroxy-2-methyl-, dodecahydro-8-hydroxy-3,6,9-tris(methylene)-2-oxoazuleno[4,5-b]furan-4-yl ester (9CI)
    • 3,8-Dihydroxy-4(15),10(14),11(13)-guaiatrien-12,6-olide; (1α,3β,5α,6α,8α)-form, 8-O-(2,3-Dihydroxy-2-methylpropanoyl)
    • Inchi: 1S/C19H24O7/c1-8-5-13(25-18(23)19(4,24)7-20)15-10(3)17(22)26-16(15)14-9(2)12(21)6-11(8)14/h11-16,20-21,24H,1-3,5-7H2,4H3
    • InChI Key: NPBDPFOGSVKPOK-UHFFFAOYSA-N
    • SMILES: C(OC1C2C(=C)C(=O)OC2C2C(CC(O)C2=C)C(=C)C1)(=O)C(O)(C)CO

3,8-Dihydroxy-4(15),10(14),11(13)-guaiatrien-12,6-olide; (1α,3β,5α,6α,8α)-form, 8-O-(2,3-Dihydroxy-2-methylpropanoyl) Related Literature

Recommended suppliers
Essenoi Fine Chemical Co., Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Jinan Hanyu Chemical Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Jinan Hanyu Chemical Co.,Ltd.
Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Amadis Chemical Company Limited
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hangzhou TSurgeX Pharmaceutical Technology Co., Ltd.